We Think That There Are Some Issues For Human Metabolome Technologies (TSE:6090) Beyond Its Promising Earnings
Aug 16
Have your own idea? Try our Stock Screener
Japanese (NIKKEI) Life Sciences Industry Analysis
UpdatedOct 01, 2025
DataAggregated Company Financials
Companies14
- 7D-1.5%
- 3M5.2%
- 1Y-4.7%
- YTD-8.6%
Over the last 7 days, the Life Sciences industry has dropped 1.0%, driven by Shin Nippon Biomedical Laboratories declining 1.4%. As for the longer term, the industry's performance has been flat for the past year. Earnings are forecast to grow by 7.7% annually.
Industry Valuation and Performance
Has the Japanese Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 01 Oct 2025 | JP¥146.2b | JP¥66.5b | JP¥1.5b | 16.9x | 100.2x | 2.2x |
| Fri, 29 Aug 2025 | JP¥147.3b | JP¥66.5b | JP¥1.5b | 16.9x | 101x | 2.2x |
| Sun, 27 Jul 2025 | JP¥140.6b | JP¥66.0b | JP¥1.1b | 16.6x | 124.6x | 2.1x |
| Tue, 24 Jun 2025 | JP¥138.8b | JP¥66.0b | JP¥1.1b | 16.5x | 122.5x | 2.1x |
| Thu, 22 May 2025 | JP¥132.9b | JP¥66.0b | JP¥1.1b | 16.4x | 117.3x | 2x |
| Sat, 19 Apr 2025 | JP¥132.6b | JP¥63.8b | JP¥963.0m | 14.1x | 137.7x | 2.1x |
| Mon, 17 Mar 2025 | JP¥162.8b | JP¥64.8b | JP¥927.4m | 15.5x | 175.5x | 2.5x |
| Wed, 12 Feb 2025 | JP¥173.7b | JP¥66.0b | JP¥1.6b | 15.9x | 109.7x | 2.6x |
| Fri, 10 Jan 2025 | JP¥164.4b | JP¥62.0b | JP¥440.7m | 17.6x | 373.1x | 2.7x |
| Sun, 08 Dec 2024 | JP¥163.1b | JP¥62.0b | JP¥825.9m | 16.9x | 197.5x | 2.6x |
| Tue, 05 Nov 2024 | JP¥149.8b | JP¥61.5b | JP¥1.8b | 21.2x | 81.3x | 2.4x |
| Thu, 03 Oct 2024 | JP¥156.8b | JP¥61.5b | JP¥1.8b | 17.9x | 85.2x | 2.6x |
| Sat, 31 Aug 2024 | JP¥164.8b | JP¥61.5b | JP¥2.1b | 20.2x | 78.1x | 2.7x |
| Mon, 29 Jul 2024 | JP¥162.5b | JP¥61.8b | JP¥3.2b | 24.9x | 50.2x | 2.6x |
| Wed, 26 Jun 2024 | JP¥167.0b | JP¥61.8b | JP¥3.2b | 26.3x | 51.6x | 2.7x |
| Fri, 24 May 2024 | JP¥161.2b | JP¥61.8b | JP¥3.4b | 25x | 48.1x | 2.6x |
| Sun, 21 Apr 2024 | JP¥175.2b | JP¥62.3b | JP¥3.3b | 14.2x | 53.2x | 2.8x |
| Tue, 19 Mar 2024 | JP¥231.1b | JP¥155.4b | JP¥8.6b | 13.9x | 26.8x | 1.5x |
| Thu, 15 Feb 2024 | JP¥235.3b | JP¥156.1b | JP¥8.9b | 14.4x | 26.3x | 1.5x |
| Sat, 13 Jan 2024 | JP¥233.8b | JP¥167.1b | JP¥8.5b | 15.8x | 27.5x | 1.4x |
| Mon, 11 Dec 2023 | JP¥227.6b | JP¥167.4b | JP¥8.7b | 14.5x | 26.2x | 1.4x |
| Wed, 08 Nov 2023 | JP¥237.7b | JP¥179.4b | JP¥12.9b | 14.5x | 18.4x | 1.3x |
| Fri, 06 Oct 2023 | JP¥248.2b | JP¥179.3b | JP¥12.8b | 15x | 19.4x | 1.4x |
| Sun, 03 Sep 2023 | JP¥268.2b | JP¥179.3b | JP¥12.8b | 17x | 21x | 1.5x |
| Tue, 01 Aug 2023 | JP¥274.8b | JP¥178.7b | JP¥15.7b | 16.4x | 17.6x | 1.5x |
| Thu, 29 Jun 2023 | JP¥277.3b | JP¥178.5b | JP¥16.2b | 17.5x | 17.1x | 1.6x |
| Sat, 27 May 2023 | JP¥274.0b | JP¥178.2b | JP¥15.9b | 15.9x | 17.2x | 1.5x |
| Mon, 24 Apr 2023 | JP¥285.9b | JP¥171.9b | JP¥13.3b | 16.5x | 21.5x | 1.7x |
| Wed, 22 Mar 2023 | JP¥302.6b | JP¥171.9b | JP¥13.3b | 16.2x | 22.8x | 1.8x |
| Fri, 17 Feb 2023 | JP¥312.4b | JP¥171.6b | JP¥12.8b | 16.7x | 24.3x | 1.8x |
| Sun, 15 Jan 2023 | JP¥292.9b | JP¥166.1b | JP¥16.2b | 14.8x | 18.1x | 1.8x |
| Tue, 13 Dec 2022 | JP¥313.8b | JP¥165.5b | JP¥16.0b | 14.6x | 19.6x | 1.9x |
| Thu, 10 Nov 2022 | JP¥309.5b | JP¥164.8b | JP¥15.5b | 15.8x | 20x | 1.9x |
| Sat, 08 Oct 2022 | JP¥327.6b | JP¥160.1b | JP¥12.4b | 17.1x | 26.5x | 2x |
Price to Earnings Ratio
26.5x
Current Industry PE
- Investors are optimistic on the Japanese Life Sciences industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 101x which is higher than its 3-year average PE of 74.3x.
- The industry is trading close to its 3-year average PS ratio of 2.0x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have declined 51% per year over the last three years,
- Revenues have also declined 25% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Japanese Healthcare industry?
| JP Market | -0.99% | |
| Healthcare | -2.44% | |
| Life Sciences | -1.48% | |
| Clinical Research and Equipment | -1.48% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6090 Human Metabolome Technologies | JP¥750.00 | 2.7% +JP¥113.8m | 25.2% | PE16.7x | |
| 130A Veritas In Silico | JP¥724.00 | 0.7% +JP¥32.4m | -28.6% | PS38.5x |